Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations

References

• Australian Cancer Network Diagnosis and Management of Lymphoma Guidelines Working Party. Guidelines for the Diagnosis and Mangement of Lymphoma. The Cancer Council Australia and Australian Cancer Network, Sydney 2005
   Google Scholar
• Harris N L, Jaffe E S, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Shipp M A, Harrington D P, Anderson J R, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Alberta Cancer Board. Clinical Practice Guidelines - Lymphoma. Alberta Cancer Board, Alberta 2006
   Google Scholar
• British Committee for Standards in Haematology. BCSH Guidelines on Diagnosis and Therapy. Nodal Non-Hodgkin's Lymphoma. British Committee for Standards in Haematology, London 2002, http://www.bcshguidelines.com/pdf/NHL_100903.pdf (accessed October 2008)
   Google Scholar
• British Committee for Standards in Haematology, Royal College of Pathologists. Best Practice in Lymphoma Diagnosis and Reporting - Specific Disease Appendix. British Committee for Standards in Haematology, Royal College of Pathologists, London 2008; 52–60, http://www.bcshguidelines.com/pdf/best_practice_lymphoma_diagnosis_appendix.pdf (accessed October 2008)
   Google Scholar
• British Committee for Standards in Haematology, Royal College of Pathologists. Best Practice in Lymphoma Diagnosis and Reporting. British Committee for Standards in Haematology, Royal College of Pathologists, London 2008; 1–52, http://www.bcshguidelines.com/pdf/best_practice_lymphoma_diagnosis.pdf (accessed October 2008)
   Google Scholar
• Smithers D W. Summary of papers delivered at the Conference on Staging in Hodgkin's Disease (Ann Arbor). Cancer Res 1971; 31: 1869–1870
   PubMed Web of Science ®Google Scholar
• Arber D A, George T I. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 2005; 29: 1549–1557
   PubMed Web of Science ®Google Scholar
• Horning S J, Rosenberg S A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984; 311: 1471–1475
   PubMed Web of Science ®Google Scholar
• Chung R, Lai R, Wei P, et al. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood 2007; 110: 1278–1282
   PubMed Web of Science ®Google Scholar
• Palacio C, Acebedo G, Navarrete M, et al. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Haematologica 2001; 86: 934–940
   PubMed Web of Science ®Google Scholar
• Campbell J, Seymour J F, Matthews J, Wolf M, Stone J, Juneja S. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Haematol 2006; 76: 473–480
   PubMed Web of Science ®Google Scholar
• Cheson B D, Horning S J, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244
   PubMed Web of Science ®Google Scholar
• Juneja S K, Wolf M M, Cooper I A. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J Clin Pathol 1990; 43: 630–632
   PubMed Web of Science ®Google Scholar
• Wang J, Weiss L M, Chang K L, et al. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 2002; 94: 1522–1531
   PubMed Web of Science ®Google Scholar
• Campbell J K, Matthews J P, Seymour J F, Wolf M M, Juneja S K. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 2003; 14: 273–276
   PubMed Web of Science ®Google Scholar
• Chudgar U, Khanduri U. Intraobserver and interobserver reproducibility of the FAB classification in acute leukaemia. Indian J Pathol Microbiol 1992; 35: 229–236
   PubMedGoogle Scholar
• Diebold J, Weisenburger D, MacLennan K A, et al. Reproducibility and prognostic value of histopathological classifications of malignant lymphomas. Prolegomena for the 1st international classification proposed by WHO. Group of the non-Hodgkin's Malignant Lymphoma Classification Project. Bull Acad Natl Med 1998; 182: 1537–1548, discussion 48–9
   PubMed Web of Science ®Google Scholar
• Hanby A M, Hall P A, Rooney N, et al. An inter-observer and intra-observer variability study on the diagnosis of lymph node biopsy specimens. Eur J Cancer 1992; 28A: 1858–1862
   PubMed Web of Science ®Google Scholar
• Talaulikar D, Dahlstrom J E, Shadbolt B, McNiven M, Broomfield A, Pidcock M. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study. Pathology 2007; 39: 580–585
   PubMed Web of Science ®Google Scholar
• Talaulikar D, Bell J, Khan K, et al. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) – a new perspective. Histopathology 2008; 52: 340–347
   PubMed Web of Science ®Google Scholar
• Talaulikar D, Dahlstrom J E, Shadbolt B, Broomfield A, McDonald A. Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL). J Histochem Cytochem 2008; 56: 893–900
   PubMed Web of Science ®Google Scholar
• Yan Y, Chan W C, Weisenburger D D, et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol 1995; 13: 1336–1342
   PubMed Web of Science ®Google Scholar
• Hanson C A, Kurtin P J, Katzmann J A, et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999; 94: 3889–3896
   PubMed Web of Science ®Google Scholar
• Naughton M J, Hess J L, Zutter M M, Bartlett N L. Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test?. Cancer 1998; 82: 1154–1159
   PubMed Web of Science ®Google Scholar
• Pittaluga S, Tierens A, Dodoo Y L, Delabie J, De Wolf-Peeters C. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Am J Clin Pathol 1999; 111: 179–184
   PubMed Web of Science ®Google Scholar
• Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom 2003; 54: 10–18
   PubMed Web of Science ®Google Scholar
• Picker L J, Weiss L M, Medeiros L J, Wood G S, Warnke R A. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987; 128: 181–201
   PubMed Web of Science ®Google Scholar
• Teruya-Feldstein J, Chiao E, Filippa D A, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004; 15: 1673–1679
   PubMed Web of Science ®Google Scholar
• Chikatsu N, Kojima H, Suzukawa K, et al. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol 2003; 16: 828–832
   PubMed Web of Science ®Google Scholar
• Alvaro-Naranjo T, Jaen-Martinez J, Guma-Padro J, Bosch-Princep R, Salvado-Usach M T. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature. Ann Hematol 2003; 82: 585–588
   PubMed Web of Science ®Google Scholar
• Perea G, Altes A, Bellido M, et al. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL). Histopathology 2004; 45: 268–274
   PubMed Web of Science ®Google Scholar
• Duggan P R, Easton D, Luider J, Auer I A. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Cancer 2000; 88: 894–899
   PubMed Web of Science ®Google Scholar
• Sah S P, Matutes E, Wotherspoon A C, Morilla R, Catovsky D. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol 2003; 56: 129–132
   PubMed Web of Science ®Google Scholar
• Dunphy C H. Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms. Am J Clin Pathol 1998; 109: 625–630
   PubMed Web of Science ®Google Scholar
• Talaulikar D, Dahlstrom J E, Shadbolt B, McDonald A. Clinical implications of immunophenotyping in staging diffuse large B-cell lymphoma. Blood (ASH Annual Meeting Abstracts) 2008; 112, Abstr 5279
   Google Scholar
• Fraga M, Brousset P, Schlaifer D, et al. Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 1995; 103: 82–89
   PubMed Web of Science ®Google Scholar
• Mazur G, Halon A, Wrobel T, Jelen M, Kuliczkowski K. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas. Neoplasma 2004; 51: 159–163
   PubMed Web of Science ®Google Scholar
• Chetty R, Echezarreta G, Comley M, Gatter K. Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma. J Clin Pathol 1995; 48: 1035–1038
   PubMed Web of Science ®Google Scholar
• Schwonzen M, Pohl C, Steinmetz T, Wickramanayake P D, Thiele J, Diehl V. Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology. Br J Haematol 1992; 81: 362–369
   PubMed Web of Science ®Google Scholar
• Miller R T, Swanson P E, Wick M R. Fixation and epitope retrieval in diagnostic immunohistochemistry: a concise review with practical considerations. Appl Immunohistochem Mol Morphol 2000; 8: 228–235
   PubMedGoogle Scholar
• Leong A S. Pitfalls in diagnostic immunohistology. Adv Anat Pathol 2004; 11: 86–93
   PubMed Web of Science ®Google Scholar
• Naresh K N, Lampert I, Hasserjian R, et al. Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol. J Clin Pathol 2006; 59: 903–911
   PubMed Web of Science ®Google Scholar
• Chadburn A, Knowles D M. Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol 1994; 102: 284–291
   PubMed Web of Science ®Google Scholar
• Isaacson P G. Haematopathology practice: the commonest problems encountered in a consultation practice. Histopathology 2007; 50: 821–834
   PubMed Web of Science ®Google Scholar
• Taniguchi M, Oka K, Hiasa A, et al. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 1998; 91: 1145–1151
   PubMed Web of Science ®Google Scholar
• Harada S, Suzuki R, Uehira K, et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes. Leukemia 1999; 13: 1441–1447
   PubMed Web of Science ®Google Scholar
• Gervasi F, Lo Verso R, Giambanco C, Cardinale G, Tomaselli C, Pagnucco G. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites. Ann NY Acad Sci 2004; 1028: 457–462
   PubMed Web of Science ®Google Scholar
• Echeverri C, Fisher S, King D, Craig F E. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry. Am J Clin Pathol 2002; 117: 615–620
   PubMed Web of Science ®Google Scholar
• Trainor K J, Brisco M J, Story C J, Morley A A. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990; 75: 2220–2222
   PubMed Web of Science ®Google Scholar
• Trainor K J, Brisco M J, Wan J H, Neoh S, Grist S, Morley A A. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 1991; 78: 192–196
   PubMed Web of Science ®Google Scholar
• Wan J H, Trainor K J, Brisco M J, Morley A A. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990; 43: 888–890
   PubMed Web of Science ®Google Scholar
• Achille A, Scarpa A, Montresor M, et al. Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations. Diagn Mol Pathol 1995; 4: 14–24
   PubMed Web of Science ®Google Scholar
• Diss T C, Pan L. Polymerase chain reaction in the assessment of lymphomas. Cancer Surv 1997; 30: 21–44
   PubMedGoogle Scholar
• van Dongen J J, Langerak A W, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317
   PubMed Web of Science ®Google Scholar
• Coad J E, Olson D J, Christensen D R, et al. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas. Am J Surg Pathol 1997; 21: 1047–1056
   PubMed Web of Science ®Google Scholar
• Crotty P L, Smith B R, Tallini G. Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma. Diagn Mol Pathol 1998; 7: 90–95
   PubMedGoogle Scholar
• Maes B, Achten R, Demunter A, Peeters B, Verhoef G, De Wolf-Peeters C. Evaluation of B cell lymphoid infiltrates in bone marrow biopsies by morphology, immunohistochemistry, and molecular analysis. J Clin Pathol 2000; 53: 835–840
   PubMed Web of Science ®Google Scholar
• Kang Y H, Park C J, Seo E J, et al. Polymerase chain reaction-based diagnosis of bone marrow involvement in 170 cases of non-Hodgkin lymphoma. Cancer 2002; 94: 3073–3082
   PubMed Web of Science ®Google Scholar
• Mitterbauer-Hohendanner G, Mannhalter C, Winkler K, et al. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia 2004; 18: 1102–1107
   PubMed Web of Science ®Google Scholar
• Talaulikar D, Gray J X, Shadbolt B, McNiven M, Dahlstrom J E. A comparative study of the quality of DNA obtained from fresh frozen and formalin-fixed decalcified paraffin-embedded bone marrow trephine biopsy specimens using two different methods. J Clin Pathol 2008; 61: 119–123
   PubMed Web of Science ®Google Scholar
• Provan A B, Hodges E, Smith A G, Smith J L. Use of paraffin wax embedded bone marrow trephine biopsy specimens as a source of archival DNA. J Clin Pathol 1992; 45: 763–765
   PubMed Web of Science ®Google Scholar
• Talaulikar D, Shadbolt B, McNiven M, Dahlstrom J E. DNA amplification from formalin-fixed decalcified paraffin-embedded bone marrow trephine specimens: does the duration of storage matter?. Pathology 2008; 40: 702–706
   PubMed Web of Science ®Google Scholar
• Nagasaka T, Lai R, Chen Y Y, et al. The use of archival bone marrow specimens in detecting B-cell non-Hodgkin's lymphomas using polymerase chain reaction methods. Leuk Lymphoma 2000; 36: 347–352
   PubMed Web of Science ®Google Scholar
• Inghirami G, Szabolcs M J, Yee H T, Corradini P, Cesarman E, Knowles D M. Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Lab Invest 1993; 68: 746–757
   PubMed Web of Science ®Google Scholar
• Lassmann S, Gerlach U V, Technau-Ihling K, Werner M, Fisch P. Application of BIOMED-2 primers in fixed and decalcified bone marrow biopsies: analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin's lymphomas. J Mol Diagn 2005; 7: 582–591
   PubMed Web of Science ®Google Scholar
• Alizadeh A A, Eisen M B, Davis R E, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
   PubMed Web of Science ®Google Scholar